• U-73122: Precision Phospholipase C Inhibitor for Cell Signal

  2026-05-02

  U-73122 is a benchmark phospholipase C inhibitor enabling precise dissection of PLC-mediated calcium flux and chemotaxis in cancer and inflammation models. Its selectivity and well-characterized performance make it indispensable for reproducible studies, as demonstrated in advanced breast cancer invasiveness research.

• Plk1 Regulation of p31comet: Control of Mitotic Checkpoint D

  2026-05-01

  This study uncovers how Polo-like kinase 1 (Plk1) phosphorylates p31comet at S102, suppressing its ability to promote the disassembly of the mitotic checkpoint complex (MCC) via TRIP13. These findings clarify a key regulatory step in mitotic checkpoint inactivation, with implications for cell cycle control and cancer research.

• U 46619: Mechanistic Insights and Advanced Protocols for Pla

  2026-04-30

  Explore U 46619 (11,9 epoxymethano-prostaglandin H2) as a precision tool for dissecting platelet aggregation and vascular dynamics. This in-depth analysis delivers advanced protocol guidance, mechanistic clarity, and practical comparison to clinical anticoagulant strategies.

• Ginsenoside Rg1: Advanced Neuroimmune Circuitry and Translat

  2026-04-30

  Explore how Ginsenoside Rg1, a triterpene saponin, redefines neuroimmune modulation through regulatory T cell mechanisms and gut-brain axis insights. This in-depth guide reveals advanced applications and translational strategies distinct from protocol-focused resources.

• miR-18a/ALOXE3 Axis Regulates Ferroptosis and Migration in G

  2026-04-29

  This study reveals that miR-18a drives glioblastoma progression by suppressing ALOXE3, thereby inhibiting ferroptosis and enhancing tumor cell migration. These insights highlight novel lipid metabolism targets for glioblastoma research and therapeutic development.

• Dual Luciferase Reporter Gene System: Precision in Gene Regu

  2026-04-29

  The Dual Luciferase Reporter Gene System from APExBIO empowers high-throughput, quantitative analysis of transcriptional regulation in mammalian cells. Its no-lysis workflow, dual-wavelength detection, and robust normalization transform complex gene expression studies into streamlined, reproducible assays.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Research

  2026-04-28

  Chlorpromazine HCl, a proven dopamine receptor antagonist, empowers neuropharmacology and infection biology studies with unmatched precision. Its high solubility and validated protocols enable robust workflows in both neuronal and host-pathogen research.

• CH 223191 as an Aryl Hydrocarbon Receptor Antagonist: Applie

  2026-04-28

  CH 223191 empowers researchers to dissect the aryl hydrocarbon receptor (AhR) signaling cascade with nanomolar precision, offering a robust platform for both environmental toxicology and regenerative medicine investigations. This guide delivers actionable protocols, troubleshooting strategies, and translational insight anchored in the latest microbiota–tryptophan–AhR axis breakthroughs.

• BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid

  2026-04-27

  BODIPY 581/591 C11 sets the benchmark for ratiometric lipid peroxidation detection, enabling precise, live-cell oxidative stress measurement and antioxidant evaluation. Its unique red-to-green emission shift and high photostability empower reliable workflows even in challenging biological systems.

• Urolithin A in Mitochondrial Biogenesis Research: Advanced W

  2026-04-27

  Urolithin A, a mitophagy activator and anti-inflammatory compound, enables high-precision cellular and mitochondrial investigations. This article delivers protocol enhancements, troubleshooting tactics, and critical insights from recent fibrosis research, setting a new standard for experimental reproducibility in mitochondrial biogenesis studies.

• Pol II Degradation Triggers Cell Death Independent of Transc

  2026-04-26

  This study demonstrates that targeted degradation of RNA Polymerase II (Pol II) initiates apoptosis independently of global transcriptional shutdown. The work uncouples Pol II's structural role from its canonical transcriptional function and offers new perspectives on cell death mechanisms relevant for cancer research.

• EdU Imaging Kits (Cy5): Precision 5-ethynyl-2'-deoxyuridine

  2026-04-25

  EdU Imaging Kits (Cy5) empower researchers with high-specificity, morphology-preserving detection of S-phase DNA synthesis. Their click chemistry workflow outperforms traditional BrdU assays and enables advanced applications in genotoxicity, metabolic reprogramming studies, and cell therapy research.

• VE-822 ATR Inhibitor: Enhancing DNA Damage Response Research

  2026-04-24

  VE-822 stands out as a potent ATR inhibitor, uniquely enabling selective sensitization of pancreatic cancer cells to chemoradiotherapy. This article bridges cutting-edge reference findings with actionable protocols, troubleshooting guidance, and advanced research applications to optimize DNA damage response studies.

• Danazol (C3644): New Insights into HPG Axis Modulation and A

  2026-04-24

  Explore the multifaceted role of Danazol in HPG axis modulation and advanced assay development. This article uniquely integrates recent animal model findings and technical parameters, offering practical guidance for researchers working with Danazol and related endocrine targets.

• EGCG-Loaded 3D Calcium Phosphate Scaffolds for Bone Repair

  2026-04-23

  This study demonstrates the utility of 3D-printed tricalcium phosphate scaffolds for localized, sustained delivery of (-)-Epigallocatechin gallate (EGCG) to promote osteogenesis and inhibit osteoclastogenesis. The approach provides a multifunctional platform for regenerating craniofacial bone defects after trauma or tumor resection, with distinct advantages over conventional grafts in supporting both bone and vascular tissue formation.

15600 records 1/1040 page Next 12345 下5页 Last page